Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, reducing genetics-focused coverage of that disease.SummaryDifference0.1%
- Check11 days agoChange DetectedUpdated the page to announce v3.2.0 with a funding-related operating status notice, replacing the previous v3.1.0. Key impact: users are informed about potential service disruptions and where to verify status.SummaryDifference0.9%
- Check18 days agoChange DetectedBroaden and update the page content: replace 'Plasma cell myeloma' with 'Multiple myeloma' and increment the revision to v3.1.0, indicating an updated topic scope and terminology.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page updates to v3.0.2 and removes the MedlinePlus Genetics topic 'Multiple myeloma'; the older revision note (v3.0.1) and the 'Back to Top' element are also removed.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page has been updated with new dates and a revision number, indicating a recent update to the content.SummaryDifference0.4%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations related to plasma cell myeloma, while removing previous location terms and drug information. The revision number has also been updated to v3.0.0.SummaryDifference1%
Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.